SenzaGen AB (OSTO:SENZA) Short Interest

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:SENZA SenzaGen AB OSTO:SENZA
72 GF Score
Price kr5.30
GF Value kr6.41
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is SenzaGen AB Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

OSTO:SENZA vs TMO, DHR, IDXX: Short Interest Comparison

For the Diagnostics & Research subindustry, SenzaGen AB's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

SenzaGen AB Short Interest vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, SenzaGen AB's Short Interest distribution charts can be found below:

* The bar in red indicates where SenzaGen AB's Short Interest falls into.


OSTO:SENZA
72GF Score
SenzaGen AB OSTO:SENZA
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is SenzaGen AB (OSTO:SENZA) Overvalued in 2026?

Based on GuruFocus' analysis, SenzaGen AB stock appears to be undervalued. The current stock price of kr5.30 is trading 17.3% below its estimated GF Value™ of kr6.41. GuruFocus considers SenzaGen AB to be Modestly Undervalued.

Key valuation signals for OSTO:SENZA:

  • Short Interest:
  • GF Value™: kr6.41 vs. price of kr5.30 (17.3% below fair value)
  • GF Score™: 72/100 with 5 warning signs

No single metric tells the full story. See the OSTO:SENZA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

SenzaGen AB Business Description

Address Scheelevagen 8, Medicon Village, Building 401, Lund, SWE, 223 63
SenzaGen AB markets, sells, and performs in vitro testing using its Genomic Allergen Rapid Detection (GARD) platform through its laboratory and a network of contract research organizations. The company provides animal-free testing solutions for chemical compounds used in industries such as cosmetics, chemicals, pharmaceuticals, medical devices, and food and nutrition. Geographically, it operates in the Americas, EMEA, and APAC, with the majority of revenue from EMEA.
72GF Score

Get the complete analysis for OSTO:SENZA

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr5.30
Price
kr6.41
GF Value